Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor‐2 in cardiovascular development and disease
Open Access
- 22 January 2009
- journal article
- review article
- Published by Wiley in Developmental Dynamics
- Vol. 238 (2), 249-264
- https://doi.org/10.1002/dvdy.21677
Abstract
Fibroblast growth factor 2 (FGF2) consists of multiple protein isoforms (low molecular weight, LMW, and high molecular weight, HMW) produced by alternative translation from the Fgf2 gene. These protein isoforms are localized to different cellular compartments, indicating unique biological activity. FGF2 isoforms in the heart have distinct roles in many pathological circumstances in the heart including cardiac hypertrophy, ischemia–reperfusion injury, and atherosclerosis. These studies suggest distinct biological activities of FGF2 LMW and HMW isoforms both in vitro and in vivo. Yet, due to the limitations that only the recombinant FGF2 LMW isoform is readily available and that the FGF2 antibody is nonspecific with regards to its isoforms, much remains to be determined regarding the role(s) of the FGF2 LMW and HMW isoforms in cellular behavior and in cardiovascular development and pathophysiology. This review summarizes the activities of LMW and HMW isoforms of FGF2 in cardiovascular development and disease. Developmental Dynamics 238:249–264, 2009.Keywords
This publication has 162 references indexed in Scilit:
- Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overloadJournal of Molecular and Cellular Cardiology, 2008
- Valvulogenesis: the moving targetPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2007
- Fibroblast growth factor-2 and cardioprotectionHeart Failure Reviews, 2007
- The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: The role of JNK signalingJournal of Molecular and Cellular Cardiology, 2007
- Reperfusion injury: Does it exist?Journal of Molecular and Cellular Cardiology, 2007
- Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2Proceedings of the National Academy of Sciences, 2006
- Survival kinases in ischemic preconditioning and postconditioningCardiovascular Research, 2006
- Administration of FGF-2 to the Heart Stimulates Connexin-43 Phosphorylation at Protein Kinase C Target SitesCell Communication & Adhesion, 2006
- Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosingEuropean Journal Of Cancer, 2006
- Protein Sorting by Transport VesiclesScience, 1996